The Department intends to amend 65D-30.0142, F.A.C., Clinical and Operational Standards for Medication-Assisted Treatment for Opioid Use Disorders to adopt federal regulations for take-home phases. This rule amendment will reduce staffing and fiscal burdens on providers of Medication-Assisted Treatment for Opioid Use Disorders, while maintaining the health and safety for individuals receiving these services. The proposed rule amendment adopts a rule substantively identical to the federal regulations adopted by the Substance Abuse and Mental Health Services Administration at Title 42 Code of Federal Regulations, Section 8.12(i)(3) (42 C.F.R 8.12(i)(3)) for take-home phases for Methadone Medication-Assisted Treatment.